XENE Annual Total Long Term Liabilities
$9.60 M
-$343.00 K-3.45%
31 December 2023
Summary:
As of January 22, 2025, XENE annual total long term liabilities is $9.60 million, with the most recent change of -$343.00 thousand (-3.45%) on December 31, 2023. During the last 3 years, it has risen by +$6.55 million (+214.89%). XENE annual total long term liabilities is now -69.50% below its all-time high of $31.49 million, reached on December 31, 2012.XENE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XENE Quarterly Long Term Liabilities
$8.40 M
-$280.00 K-3.23%
30 September 2024
Summary:
As of January 22, 2025, XENE quarterly total long term liabilities is $8.40 million, with the most recent change of -$280.00 thousand (-3.23%) on September 30, 2024. Over the past year, it has dropped by -$280.00 thousand (-3.23%). XENE quarterly long term liabilities is now -47.05% below its all-time high of $15.86 million, reached on March 31, 2019.XENE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XENE Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.5% | -3.2% |
| 3 y3 years | +214.9% | -18.3% |
| 5 y5 years | -36.0% | -18.3% |
XENE Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.5% | +25.5% | -19.5% | +17.4% |
| 5 y | 5-year | -22.2% | +214.9% | -31.9% | +4367.6% |
| alltime | all time | -69.5% | -47.0% |
Xenon Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.40 M(-3.2%) |
| June 2024 | - | $8.68 M(-4.6%) |
| Mar 2024 | - | $9.10 M(-5.2%) |
| Dec 2023 | $9.60 M(-3.4%) | $9.60 M(-1.6%) |
| Sept 2023 | - | $9.76 M(-5.1%) |
| June 2023 | - | $10.28 M(-1.4%) |
| Mar 2023 | - | $10.43 M(+4.9%) |
| Dec 2022 | $9.95 M(+30.0%) | $9.95 M(+39.0%) |
| Sept 2022 | - | $7.16 M(-8.8%) |
| June 2022 | - | $7.85 M(-4.5%) |
| Mar 2022 | - | $8.22 M(+7.5%) |
| Dec 2021 | $7.65 M(+150.9%) | $7.65 M(+199.1%) |
| Sept 2021 | - | $2.56 M(-6.8%) |
| June 2021 | - | $2.75 M(-5.4%) |
| Mar 2021 | - | $2.90 M(-4.9%) |
| Dec 2020 | $3.05 M(-75.3%) | $3.05 M(+1522.3%) |
| Sept 2020 | - | $188.00 K(-41.8%) |
| June 2020 | - | $323.00 K(-40.3%) |
| Mar 2020 | - | $541.00 K(-95.6%) |
| Dec 2019 | $12.34 M | $12.34 M(-2.4%) |
| Sept 2019 | - | $12.64 M(-8.2%) |
| June 2019 | - | $13.78 M(-13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $15.86 M(+5.6%) |
| Dec 2018 | $15.01 M(+146.0%) | $15.01 M(+0.9%) |
| Sept 2018 | - | $14.89 M(+27.0%) |
| June 2018 | - | $11.72 M(+114.0%) |
| Mar 2018 | - | $5.48 M(-10.3%) |
| Dec 2017 | $6.10 M(>+9900.0%) | $6.10 M(>+9900.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2016 | - | $86.00 K(-14.9%) |
| June 2016 | - | $101.00 K(-13.7%) |
| Mar 2016 | - | $117.00 K(-12.0%) |
| Dec 2015 | $133.00 K(-62.3%) | $133.00 K(-10.7%) |
| Sept 2015 | - | $149.00 K(-9.1%) |
| June 2015 | - | $164.00 K(-8.9%) |
| Mar 2015 | - | $180.00 K(-49.0%) |
| Dec 2014 | $353.00 K(-97.1%) | $353.00 K(-87.5%) |
| Sept 2014 | - | $2.82 M(-55.7%) |
| June 2014 | - | $6.38 M(-47.6%) |
| Dec 2013 | $12.17 M(-61.4%) | $12.17 M |
| Dec 2012 | $31.49 M | - |
FAQ
- What is Xenon Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Xenon Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Xenon Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of XENE is $9.60 M
What is the all time high annual total long term liabilities for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual total long term liabilities is $31.49 M
What is Xenon Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, XENE annual total long term liabilities has changed by -$343.00 K (-3.45%)
What is Xenon Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of XENE is $8.40 M
What is the all time high quarterly long term liabilities for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly total long term liabilities is $15.86 M
What is Xenon Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, XENE quarterly total long term liabilities has changed by -$280.00 K (-3.23%)